These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38642125)

  • 41. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer.
    Galalae RM; Martinez A; Mate T; Mitchell C; Edmundson G; Nuernberg N; Eulau S; Gustafson G; Gribble M; Kovács G
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1048-55. PubMed ID: 15001244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dose escalation with external beam radiation therapy and high-dose-rate brachytherapy combined with long-term androgen deprivation therapy in high and very high risk prostate cancer: Comparison of two consecutive high-dose-rate schemes.
    Olarte A; Cambeiro M; Moreno-Jiménez M; Arbea L; Pérez-Gracia JL; Gil-Bazo I; Pascual I; Aristu J; Martínez-Monge R
    Brachytherapy; 2016; 15(2):127-35. PubMed ID: 26832677
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beyond transanal total mesorectal excision: short-term outcomes of transanal total mesorectal excision in locally advanced rectal cancer requiring resection beyond total mesorectal excision.
    Larach JT; Rajkomar AKS; Smart PJ; McCormick JJ; Heriot AG; Warrier SK
    Colorectal Dis; 2021 Apr; 23(4):823-833. PubMed ID: 33217140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rectal cancer and inflammatory bowel disease: natural history and implications for radiation therapy.
    Green S; Stock RG; Greenstein AJ
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):835-40. PubMed ID: 10386640
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neoadjuvant radiation therapy prior to total mesorectal excision for rectal cancer is not associated with postoperative complications using current techniques.
    Milgrom SA; Goodman KA; Nash GM; Paty PB; Guillem JG; Temple LK; Weiser MR; Garcia-Aguilar J
    Ann Surg Oncol; 2014 Jul; 21(7):2295-302. PubMed ID: 24604589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer.
    Coco C; Delrio P; Rega D; Amodio LE; Pucciarelli S; Spolverato G; Belluco C; Lauretta A; Poggioli G; Rocco G; Bianco F; Marsanic P; Sica G; Tondolo V; Rizzo G;
    Colorectal Dis; 2024 Feb; 26(2):281-289. PubMed ID: 38131642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Previous radiation for prostate neoplasm alters surgical and oncologic outcomes after rectal cancer surgery.
    Guandalino M; Dupré A; François M; Leroy B; Antomarchi O; Buc E; Dubois A; Guy L; Pezet D; Gagnière J
    J Surg Oncol; 2015 Dec; 112(8):802-8. PubMed ID: 26511216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service.
    Enker WE; Merchant N; Cohen AM; Lanouette NM; Swallow C; Guillem J; Paty P; Minsky B; Weyrauch K; Quan SH
    Ann Surg; 1999 Oct; 230(4):544-52; discussion 552-4. PubMed ID: 10522724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Individualizing surgical treatment based on tumour response following neoadjuvant therapy in T4 primary rectal cancer.
    Denost Q; Kontovounisios C; Rasheed S; Chevalier R; Brasio R; Capdepont M; Rullier E; Tekkis PP
    Eur J Surg Oncol; 2017 Jan; 43(1):92-99. PubMed ID: 27717529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 51. External-beam radiation therapy and high-dose rate brachytherapy combined with long-term androgen deprivation therapy in high and very high prostate cancer: preliminary data on clinical outcome.
    Martínez-Monge R; Moreno M; Ciérvide R; Cambeiro M; Pérez-Gracia JL; Gil-Bazo I; Gaztañaga M; Arbea L; Pascual I; Aristu J
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e469-76. PubMed ID: 22284039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
    Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306
    [No Abstract]   [Full Text] [Related]  

  • 53. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
    Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
    Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transanal minimally invasive surgery for total mesorectal excision (TAMIS-TME): results and experience with the first 20 patients undergoing curative-intent rectal cancer surgery at a single institution.
    Atallah S; Martin-Perez B; Albert M; deBeche-Adams T; Nassif G; Hunter L; Larach S
    Tech Coloproctol; 2014 May; 18(5):473-80. PubMed ID: 24272607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is it safe to omit neoadjuvant chemo-radiation in mucinous rectal carcinoma?
    Madbouly KM; Mashhour AN; Omar W
    Int J Surg; 2015 Nov; 23(Pt A):120-7. PubMed ID: 26397210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients.
    Law WL; Chu KW
    Ann Surg; 2004 Aug; 240(2):260-8. PubMed ID: 15273550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy.
    Dong Y; Ruth KJ; Churilla TM; Viterbo R; Sobczak ML; Smaldone MC; Chen DY; Uzzo RG; Hallman MH; Horwitz EM
    Can J Urol; 2017 Feb; 24(1):8656-8662. PubMed ID: 28263132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. External beam radiation therapy and a low-dose-rate brachytherapy boost without or with androgen deprivation therapy for prostate cancer.
    Strom TJ; Hutchinson SZ; Shrinath K; Cruz AA; Figura NB; Nethers K; Biagioli MC; Fernandez DC; Heysek RV; Wilder RB
    Int Braz J Urol; 2014; 40(4):474-83. PubMed ID: 25251952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.